CD8A and neoplasm: LAIR-1 was multiplexed with lymphocyte markers (CD45RA, CD4, CD8, CD20, CD56), myeloid monocyte markers (CD14, CD68, CD163 for macrophages and CD66b for neutrophils), fibroblast marker (SMA), hematopoietic progenitor cells (HPC, CD34) and tumor marker (pan CK).